Monitoring the electrophysiological effects of hydroquinidine non-invasively in patients with Brugada syndrome

Back

ESC Professional Premium Access

Monitoring the electrophysiological effects of hydroquinidine non-invasively in patients with Brugada syndrome

Session: Ion channel diseases: risk stratification and treatment

Topic: Ion Channel Disorders

Speaker: Doctor J. Isbister (Sydney, AU)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Julia Clair Isbister

Garvan Institute of Medical Research, Sydney (Australia)

1 presentation

0 follower

7 more presentations in this session

An online international survey study into the incidence and potential reasons of therapy non-adherence in catecholaminergic polymorphic ventricular tachycardia: preliminary results

Speaker: Mrs P. Peltenburg (Amsterdam, NL)

Roles of atrial arrhythmias in triggering torsade de pointes in patients with acquired long QT syndrome

Speaker: Doctor R. Tochibora (Gifu, JP)

Prevalence and prognostic value of epilepsy and Brugada syndrome

Speaker: Miss E. Rossetto (Milan, IT)

Characterization of the cardiac and non-cardiac phenotype associated with genetic variants in KCNJ2

Speaker: Doctor D. Abrams (Boston, US)

Interpretable machine learning model using Extreme Gradient Boosting with Nonnegative Matrix Factorization improves the accuracy of arrhythmic risk prediction in Brugada Syndrome

Speaker: Professor G. Tse (Hong Kong, CN)

Access

Abstract

Slides

Access the full session

Ion channel diseases: risk stratification and treatment

Speakers: Doctor J. Isbister, Mrs P. Peltenburg, Doctor R. Tochibora, Miss E. Rossetto, Doctor D. Abrams...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources